Table 1.

Patient characteristics

Case	Age/sex	Site of recurrence	Tumor size (mm)	Time to recurrence (month)	Previous operation	Original stage	Original Tumor site	LN dissection	Original pathology	Adjuvant CT
1	59/M	head of pancreas	30	7	TG	T4N1M0	lower	D2	intestinal	yes
2	65/M	omental bursa	50	11	PG	T3N1M0	lower	D2	intestinal	yes
3	62/F	omental bursa	50	18	PG	T2N2M0	middle	D2	intestinal	yes
4	83/M	porta hepatis	25	32	PG	T2N1M0	lower	D1	intestinal	no
5	45/F	tail of pancreas	60	16	TG	T4N2M0	middle	D2	diffuse	yes
6	66/M	PALN	25	28	PG	T3N2M0	upper	D2	intestinal	yes
7	49/M	PALN	35	17	PG	T3N1M0	lower	D2	intestinal	yes
8	79 M	hilum of spleen	28	10	PG	T2N2M0	lower	D1	intestinal	yes
9	67/F	omental bursa	25	14	TG	T3N1M0	lower	D2	diffuse	yes
10	72/M	omental bursa	45	13	PG	T2N1M0	upper	D2	intestinal	no
11	49/M	head of pancreas	25	14	PG	T3N1M0	lower	D2	intestinal	yes
12	42/M	porta hepatis	40	16	PG	T3N1M0	middle	D2	diffuse	yes
13	66/M	porta hepatis	22	19	PG	T3N1M0	lower	D2	intestinal	yes
14	72/F	head of pancreas	38	10	TG	T4N1M0	lower	D1	diffuse	yes
15	63/M	PALN	20	26	PG	T2N1M0	upper	D2	intestinal	yes
16	70/M	omental bursa	26	18	TG	T4N0M0	lower	D2	diffuse	yes
17	62/F	omental bursa	55	24	PG	T3N1M0	middle	D2	intestinal	yes
18	45/F	tail of pancreas	43	20	PG	T2N2M0	lower	D2	intestinal	yes
19	55/F	PALN	52	16	PG	T1N2M0	upper	D1	intestinal	yes
20	58/M	PALN	22	30	PG	T3N1M0	lower	D2	intestinal	yes
21	71/M	hilum of spleen	45	9	TG	T$N2M0	lower	D2	diffuse	yes
22	62/F	omental bursa	48	24	TG	T3N1M0	middle	D2	intestinal	yes
23	45/M	PALN	25	23	PG	T2N1M0	lower	D2	intestinal	yes
24	68/F	tail of pancreas	38	32	PG	T2N1M0	lower	D2	intestinal	yes
25	71/M	PALN	35	36	PG	T2N1M0	upper	D2	intestinal	no
26	76/M	porta hepatis	22	24	PG	T4N0M0	upper	D1	intestinal	yes
27	49/F	omental bursa	30	11	TG	T3N2M0	middle	D2	diffuse	yes
28	79/M	PALN	20	14	PG	T3N1M0	lower	D1	intestinal	no

PALN:para-aortic lymph node; TG: total gastrectomy; PG: partial gastrectomy; TNM stage: International Union Against Cancer (UICC 2002) TNM system; LN: lymph node; CT: chemotherapy.